Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry

CompletedOBSERVATIONAL
Enrollment

415

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Biliary Strictures
Interventions
DEVICE

WallFlex™ Biliary RX Fully Covered Stent System RMV

For use in the palliative treatment of biliary strictures produced by malignant neoplasms, and for treatment of benign biliary strictures

DEVICE

WallFlex™ Biliary RX Partially Covered Stent System

For use in the palliative treatment of biliary strictures produced by malignant neoplasms.

DEVICE

WallFlex™ Biliary RX Uncovered Stent System

For use in the palliative treatment of biliary strictures produced by malignant neoplasms.

Trial Locations (12)

T2N 2T9

Peter Lougheed Centre, Calgary

T5H 3V9

Royal Alexandra Hospital, Edmonton

T6G 2P4

University of Alberta Hospital, Edmonton

V6Z 2K5

Providence Health - St. Paul's Hospital, Vancouver

V8R 1J8

Victoria General Hospital, Victoria

B3H 2Y9

Queen Elizabeth II Health Sciences Center, Halifax

L6J 3L7

Oakville-Trafalgar Memorial Hospital, Oakville

K1H 8L6

The Ottawa Hospital, Ottawa

M5B 1W8

St. Michael's Hospital, Toronto

J4V 2H1

Hopital Charles Le Moyne, Greenfield Park

H2X 3J4

CHUM - Hopital Saint-Luc, Montreal

J1K 2R1

CHUS Hotel Dieu, Sherbrooke

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY